NDC properties for "Jatenzo 158 MG Oral Capsule" (RxCUI 2201640)
About this data
The tables show NDC propoerties for Jatenzo 158 MG Oral Capsule with the RxCUI 2201640
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product
Details for Jatenzo 158 MG Oral Capsule (RxCUI 2201640)
| MMSL_CODE | BD36357 |
|---|---|
| NDA | NDA206089 |
| RxCUI | 2201640 |
| SPL_SET_ID | ed7b5d41-7475-4c10-99b9-b62b3434ae60 |
| Prescribable Synonym | JATENZO 158 MG Oral Capsule |
| RXNAV_STR | Jatenzo 158 MG Oral Capsule |
| RxNorm Name | testosterone undecanoate 158 MG Oral Capsule [Jatenzo] |
| RxNorm Synonym | Jatenzo 158 MG Oral Capsule |
| Related queries | Interactions (for RxCUI 2201640) |
NDC Properties
NDC Item 69087015812
| NDC 9 | 69087-158 |
|---|---|
| NDC 10 | 69087-158-12 |
| NDC Item | 69087015812 |
| Packaging | 12 BOTTLE, PLASTIC in 1 BOX (69087-158-12) / 120 CAPSULE, LIQUID FILLED in 1 BOTTLE, PLASTIC |
| COLORTEXT | red(red (opaque)) |
| Color | C48326 __ |
| DCSA | CIII |
| FDA SPL set id | 723744 |
| Imprint code | 158 |
| Labeler | TOLMAR Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA |
| Marketing effective time low | 2019-08-01 |
| Marketing status | ACTIVE |
| NDA | NDA206089 |
| Score | 1 |
| Shapetext | CAPSULE |
| Shape | C48336 |
| Size | 21 mm |
| Related queries | Properties for NDC 9 69087-158 |